Dr. Taleb Bohlaiqa
Oncology consultant
CONSULTANT MEDICAL ONCOLOGY , HEAD OF MEDICALL ONCOLOGY DEPARTMENT AT PSMMC.
14 : 30 – 14 : 40
23 June | 2023 Day 1
EMERALD phase 3 trial of elacestrant versus standard of care endocrine therapy in patients with ER+/HER2- metastatic breast cancer: Updated results by duration of prior CDK4/6i in metastatic setting (San Antonio 2022) .
15 : 55 – 16 : 25
23 June | 2023 Day 1
Satellite symposium (Lilly) Topic: Updates on CDK4/6 in the Management of EBC
Chair Person : Dr. Taleb Bohlaiaqh
Speaker : Andreas Markis (UK)
16 : 25 – 17 : 05
23 June | 2023 Day 1
Satellite Symposium (Novartis) Topic: Updates in Early Breast Cancer Management
ChairPerson :Dr. Taleb Bohlaiaqh
Speaker :Dr. Essam Murshid
19 : 00 – 19 : 30
23 June | 2023 Day 1
Satellite symposium(Pfizer) First line treatment of ALK+ mNSCLC
ChairPerson : Dr. Taleb Bohlaiaqh
Speaker : Dr. Mervat Mahrous
